-
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
Cell. 1996 May 31;85(5):733-44
PMID: 8646781
-
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
Cell. 1996 May 31;85(5):721-32
PMID: 8646780
-
Transforming growth factor-beta and p27 expression in pituitary cells.
Endocrinology. 1996 Jul;137(7):3051-60
PMID: 8770931
-
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
J Immunol. 1984 Oct;133(4):1710-5
PMID: 6206131
-
Prolactin and growth hormone synthesis and thymidine incorporation in dissociated rat pituitary tumor cells.
Proc Soc Exp Biol Med. 1986 Jan;181(1):18-23
PMID: 3945620
-
Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10.
Hum Genet. 1989 Oct;83(3):297-9
PMID: 2571566
-
Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes.
J Cell Sci. 1989 Apr;92 ( Pt 4):531-40
PMID: 2689459
-
Monoclonal antibody Ki-67: its use in histopathology.
Histopathology. 1990 Dec;17(6):489-503
PMID: 2076881
-
Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.
J Pathol. 1992 Sep;168(1):85-6
PMID: 1453271
-
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25
PMID: 8242752
-
p21 is a universal inhibitor of cyclin kinases.
Nature. 1993 Dec 16;366(6456):701-4
PMID: 8259214
-
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
Genes Dev. 1994 Jan;8(1):9-22
PMID: 8288131
-
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
Cell. 1994 Jul 15;78(1):59-66
PMID: 8033212
-
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Cell. 1994 Jul 15;78(1):67-74
PMID: 8033213
-
G1 phase progression: cycling on cue.
Cell. 1994 Nov 18;79(4):551-5
PMID: 7954821
-
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
Cell. 1994 Nov 18;79(4):573-82
PMID: 7954824
-
Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Genes Dev. 1994 Dec 15;8(24):2939-52
PMID: 8001816
-
Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
Cancer Res. 1995 Mar 15;55(6):1206-10
PMID: 7882309
-
p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
Cancer Res. 1995 Mar 15;55(6):1211-4
PMID: 7882310
-
Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
Cancer Res. 1995 Apr 1;55(7):1413-6
PMID: 7882344
-
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
Genes Dev. 1995 Mar 15;9(6):639-49
PMID: 7729683
-
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Genes Dev. 1995 Mar 15;9(6):650-62
PMID: 7729684
-
Cell-cycle regulators and cancer.
Trends Genet. 1995 Apr;11(4):136-40
PMID: 7732591
-
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Mol Cell Biol. 1995 May;15(5):2672-81
PMID: 7739547
-
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Cancer Res. 1995 Jun 1;55(11):2266-9
PMID: 7757974
-
Inhibitors of mammalian G1 cyclin-dependent kinases.
Genes Dev. 1995 May 15;9(10):1149-63
PMID: 7758941
-
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
Cancer Res. 1995 Jul 1;55(13):2713-8
PMID: 7796391
-
Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.
Cancer Res. 1995 Aug 1;55(15):3250-3
PMID: 7614457
-
Role of the cyclin-dependent kinase inhibitors in the development of cancer.
Blood. 1995 Aug 1;86(3):841-54
PMID: 7620180
-
Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
Mol Biol Cell. 1995 Sep;6(9):1197-213
PMID: 8534916
-
Translational control of p27Kip1 accumulation during the cell cycle.
Science. 1996 Mar 29;271(5257):1861-4
PMID: 8596954
-
Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1.
J Clin Invest. 1996 Apr 15;97(8):1983-8
PMID: 8621784
-
The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3259-63
PMID: 8622924
-
p27/Kip1 mutation found in breast cancer.
Cancer Res. 1996 May 15;56(10):2400-4
PMID: 8625318
-
Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle.
Science. 1996 May 10;272(5263):877-80
PMID: 8629023
-
Frequent loss of the P16INK4a gene product in human pituitary tumors.
Cancer Res. 1996 Jun 1;56(11):2493-6
PMID: 8653683
-
Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Cell. 1996 May 31;85(5):707-20
PMID: 8646779
-
High frequency of aberrant p16(INK4A) expression in human breast cancer.
Am J Pathol. 1996 Jul;149(1):15-20
PMID: 8686738